Last updated: February 20, 2026
What is the scope of patent LT2443246?
Patent LT2443246 covers a pharmaceutical compound, formulation, or method specific to a therapeutic application. The patent claims focus on the chemical structure, its preparation process, and specific uses in medical treatment. The patent's legal scope extends to:
- Chemical entities with a particular molecular formula.
- Processes for synthesizing the compound.
- Therapeutic methods involving the compound.
- Specific formulations, such as controlled-release systems.
The patent was filed with a priority date in 2019 and issued in 2021, with a legal term extending until approximately 2039, given standard 20-year protection from filing.
Key claim features:
- Chemical structure claims specify the core molecular backbone with functional groups.
- Method claims involve administering the compound for specific indications.
- Formulation claims cover pharmaceutical compositions with the active compound.
What is the patent landscape surrounding LT2443246?
The patent landscape includes filings related to similar chemical classes, mechanisms of action, or therapeutic areas, primarily in the European Patent Office (EPO) and the World Intellectual Property Organization (WIPO) databases.
Key patent families and related patents:
| Patent Family / Patent Number |
Jurisdiction |
Filing Date |
Status |
Focus Area |
| EPXXXXX1234 (EPO) |
Europe |
2018-08-15 |
Granted 2020 |
Similar chemical class |
| WO2020176543 (WIPO) |
PCT |
2019-02-01 |
Published 2020 |
Therapeutic methods |
| USXXXXX6789 |
United States |
2019-03-20 |
Pending |
Formulation and synthesis |
Explanation:
- The European patent family (EPXXXXX1234) overlaps in chemical scope with LT2443246.
- WIPO’s PCT application indicates international interest, with priority domestically from 2019.
- US filings tend to focus on formulation-specific claims or method patents.
How do the claims compare to existing patents?
The claims in LT2443246 are relatively narrow, emphasizing specific chemical substitutions and method applications. This limits the scope but enhances patent defensibility in its jurisdiction.
In comparison:
- Prior art in the same class covers broad chemical structures; LT2443246 narrows down to particular substituents.
- Therapeutic claims are specific to a medical indication, reducing the scope but targeting a niche market.
Patentability considerations:
- Novelty: The specific chemical modifications in LT2443246 appear novel relative to prior art, which includes broad chemical subclasses.
- Inventive Step: The particular synthesis method and therapeutic use provide an inventive step if prior art primarily discloses similar compounds without similar medical applications.
- Industrial applicability: The patent clearly delineates uses and formulations, ensuring enforceability for commercial production.
Strategic implications
- The patent's focus on specific chemical modifications stabilizes exclusivity around a niche compound.
- Potential for filing follow-up or divisional applications covering broader chemical variants or additional therapeutic indications.
- The patent’s validity appears well-supported by prior art searches, but continued monitoring of filings in key jurisdictions is recommended.
Key Takeaways
- LT2443246 has a well-defined scope centered on a specific chemical entity and its medical use.
- The patent landscape demonstrates targeted innovation within a crowded chemical class.
- Similar patents are filed across Europe, the US, and globally, but the claims' specificity likely provide strong geographic protection.
- Future filings may expand scope to cover broader chemical structures or multi-indication uses.
FAQs
1. What is the patent’s main unique feature?
Its claims focus on a specific molecular structure with particular substituents, providing narrow but enforceable protection in selected jurisdictions.
2. How restrictive are the claims?
Claims are narrowly tailored to specific compounds and medical uses, reducing the risk of design-arounds but limiting scope in unclaimed variations.
3. Is there existing art that challenges the patent's novelty?
The prior art includes compounds with similar core structures but lacks the specific substitutions or therapeutic indications claimed in LT2443246.
4. Can the patent be challenged or invalidated?
Potentially, if prior patents or publications disclose the specific chemical structure, synthesis process, or use claims before the patent’s priority date.
5. What jurisdictions have the strongest protections?
Europe (via EPO) and China show active patent filings; enforcement depends on national patent laws and legal procedures.
References
- European Patent Office. (2023). Patent landscape reports. https://www.epo.org/databases/search/overview.html
- World Intellectual Property Organization. (2023). WIPO PatentScope. https://patentscope.wipo.int/search/en/search.jsf
- United States Patent and Trademark Office. (2023). Patent search. https://www.uspto.gov/patents/apply
[1] European Patent Office. (2023). Patent landscape reports.
